TY - JOUR
T1 - Strong and positive association of endothelin-1 with AGEs in PCOS
T2 - A causal relationship or a bystander?
AU - Charikleia, Christakou
AU - Frangiskos, Economou
AU - Sarantis, Livadas
AU - Christina, Piperi
AU - Christos, Adamopoulos
AU - Evangelos, Marinakis
AU - Evanthia, Diamanti Kandarakis
PY - 2011
Y1 - 2011
N2 - Objective: Advanced glycation end products (AGEs) activate the intracellular Nuclear Factor-χB pathway in endothelial cells, leading to production of endothelin-1 (ET-1), a peptide which causes endothelial dysfunction. The aim of the present study was to assess ET-1 and AGEs levels in women with polycystic ovary syndrome (PCOS) and controls and to investigate any potential relationship between them. DESIGN: Metabolic and hormonal data from 75 women with PCOS and 25 controls, matched for age and BMI were analyzed and correlated to AGEs and ET-1 levels. Results: Serum levels of ET-1 (1.55±0.13 vs. 0.37±0.10 pmol/l, p:0.003) and AGEs (8.34±1,81 vs. 5.77±0.78U/ml, p:0.002) were significantly higher in the PCOS group. ET-1 was correlated with AGES (r:0.54, p<0.001), Testosterone (r: 0.38, p<0.001), ΔA4 (r: 0.41, p<0.001) and FAI (r: 0.21, p<0.05). However, multiple linear regression analysis in the total study population showed that ET-1 was positively associated only with AGES (β: 0.22, p<0.001). Conclusions: ET-1 levels were positively and strongly associated with AGEs in both PCOS women and controls, suggesting that the detrimental effect of AGEs on endothelial cells may involve increased ET-1 production.
AB - Objective: Advanced glycation end products (AGEs) activate the intracellular Nuclear Factor-χB pathway in endothelial cells, leading to production of endothelin-1 (ET-1), a peptide which causes endothelial dysfunction. The aim of the present study was to assess ET-1 and AGEs levels in women with polycystic ovary syndrome (PCOS) and controls and to investigate any potential relationship between them. DESIGN: Metabolic and hormonal data from 75 women with PCOS and 25 controls, matched for age and BMI were analyzed and correlated to AGEs and ET-1 levels. Results: Serum levels of ET-1 (1.55±0.13 vs. 0.37±0.10 pmol/l, p:0.003) and AGEs (8.34±1,81 vs. 5.77±0.78U/ml, p:0.002) were significantly higher in the PCOS group. ET-1 was correlated with AGES (r:0.54, p<0.001), Testosterone (r: 0.38, p<0.001), ΔA4 (r: 0.41, p<0.001) and FAI (r: 0.21, p<0.05). However, multiple linear regression analysis in the total study population showed that ET-1 was positively associated only with AGES (β: 0.22, p<0.001). Conclusions: ET-1 levels were positively and strongly associated with AGEs in both PCOS women and controls, suggesting that the detrimental effect of AGEs on endothelial cells may involve increased ET-1 production.
KW - Advanced glycation end products
KW - Androgens
KW - Endothelin-1
KW - Insulin
KW - Pcos
UR - http://www.scopus.com/inward/record.url?scp=84855507649&partnerID=8YFLogxK
U2 - 10.14310/horm.2002.1320
DO - 10.14310/horm.2002.1320
M3 - Article
C2 - 22281885
AN - SCOPUS:84855507649
VL - 10
SP - 292
EP - 297
JO - Hormones
JF - Hormones
SN - 1109-3099
IS - 4
ER -